Literature DB >> 30337329

Synthetic biodegradable alternatives to the use of the amniotic membrane for corneal regeneration: assessment of local and systemic toxicity in rabbits.

Charanya Ramachandran1, Virender S Sangwan1, Ilida Ortega2, Upendra Bhatnagar3, Sadik Mohmad Abdulhamid Mulla3, Rob McKean4, Sheila MacNeil5.   

Abstract

AIM: The aim of this study was to assess the local and systemic response to poly-lactic co-glycolic acid (PLGA) 50:50 membranes, developed as synthetic biodegradable alternatives to the use of human donor amniotic membrane in the treatment of limbal stem cell deficiency.
METHODS: PLGA membranes of 2  cm diameter and 50  µm thickness were placed on one eye of rabbits and secured in place using fibrin glue and a bandage contact lens, suturing the eye close with a single stitch. Control animals were treated identically, with the absence of the membranes. Plain and microfabricated electrospun membranes (containing micropockets which roughly emulate the native limbal niche) were examined over 29 days. All animals were subjected to a detailed gross and histopathological observation as well as a detailed examination of the eye.
RESULTS: Application of the membranes both with and without microfabricated pockets did not adversely affect animal welfare. There was complete degradation of the membranes by day 29. The membranes did not induce any significant local or systemic toxicity. Conjunctival congestion and corneal vascularisation were noted in a few control and PLGA-treated animals. Intraocular pressure was normal and the retinal status was unaltered. The ocular surface was clear and intact in all animals by the end of 29  days.
CONCLUSION: Membranes of 50:50 PLGA can be safely applied to rabbit corneas without inducing any local or systemic toxicity and these break down completely within 29 days. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cornea; ocular surface; stem cells

Mesh:

Substances:

Year:  2018        PMID: 30337329     DOI: 10.1136/bjophthalmol-2018-312055

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

Review 1.  The progress in techniques for culturing human limbal epithelial stem cells.

Authors:  Yan Shen; Qihua Le
Journal:  Hum Cell       Date:  2022-10-01       Impact factor: 4.374

2.  Bioengineered Human Stromal Lenticule for Recombinant Human Nerve Growth Factor Release: A Potential Biocompatible Ocular Drug Delivery System.

Authors:  Leonardo Mastropasqua; Mario Nubile; Giuseppina Acerra; Nicola Detta; Letizia Pelusi; Manuela Lanzini; Simone Mattioli; Manuela Santalucia; Laura Pietrangelo; Marcello Allegretti; Harminder S Dua; Jodhbir S Mehta; Assunta Pandolfi; Domitilla Mandatori
Journal:  Front Bioeng Biotechnol       Date:  2022-06-23

3.  Identification of a fibrin concentration that promotes skin cell outgrowth from skin explants onto a synthetic dermal substitute.

Authors:  Kavita Sharma; Anthony J Bullock; Victoria Giblin; Sheila MacNeil
Journal:  JPRAS Open       Date:  2020-04-21

4.  Proof-of-concept study of electrospun PLGA membrane in the treatment of limbal stem cell deficiency.

Authors:  Charanya Ramachandran; Pallavi Deshpande; Ilida Ortega; Farshid Sefat; Rob McKean; Mala Srivastava; Sheila MacNeil; Sayan Basu; Virender Singh Sangwan
Journal:  BMJ Open Ophthalmol       Date:  2021-07-26

Review 5.  Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge.

Authors:  Hoda Elkhenany; Azza El-Derby; Mohamed Abd Elkodous; Radwa A Salah; Ahmed Lotfy; Nagwa El-Badri
Journal:  Stem Cell Res Ther       Date:  2022-01-10       Impact factor: 6.832

6.  Fibrin-Plasma Rich in Growth Factors Membrane for the Treatment of a Rabbit Alkali-Burn Lesion.

Authors:  Ronald M Sánchez-Ávila; Natalia Vázquez; Manuel Chacón; Mairobi Persinal-Medina; Agustín Brea-Pastor; Silvia Berisa-Prado; Luis Fernández-Vega-Cueto; Eduardo Anitua; Álvaro Meana; Jesús Merayo-Lloves
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.